ABIN251509
antibody from antibodies-online
Targeting: EHMT2
BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [3]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN251509 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Ankyrin Repeat-Containing Protein (EHMT2) (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Rat
- Host
- Rabbit
- Epitope
- C-Term
- Vial size
- 100 μL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.
Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.
Bantscheff M, Hopf C, Savitski MM, Dittmann A, Grandi P, Michon AM, Schlegl J, Abraham Y, Becher I, Bergamini G, Boesche M, Delling M, Dümpelfeld B, Eberhard D, Huthmacher C, Mathieson T, Poeckel D, Reader V, Strunk K, Sweetman G, Kruse U, Neubauer G, Ramsden NG, Drewes G
Nature biotechnology 2011 Mar;29(3):255-65
Nature biotechnology 2011 Mar;29(3):255-65
Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.
Cho HS, Kelly JD, Hayami S, Toyokawa G, Takawa M, Yoshimatsu M, Tsunoda T, Field HI, Neal DE, Ponder BA, Nakamura Y, Hamamoto R
Neoplasia (New York, N.Y.) 2011 Aug;13(8):676-84
Neoplasia (New York, N.Y.) 2011 Aug;13(8):676-84
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC